Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
10 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
UCB Ventures Belgium from Anderlecht, company number BE0668388891, closed financial year 2025 with a result of € 1.9 million after tax. Compared with financial year 2024, the result moved from € 1.2 million to € 1.9 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.
€ 28.7 million
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.9 million
▲ 67% vs 2024
Profit after tax over the fiscal year.
€ 136,662
▼ 95% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 725,136.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 27,150
▼ 8% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 693 days on average.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Profit after taxes | € -1,464,668 | € -7,875,172 | € 1,164,998 | € 1,947,332 | ▲ 67% |
| Equity | € 33,487,978 | € 25,612,806 | € 26,777,804 | € 28,725,136 | ▲ 7% |
| Total debts | € 60,056 | € 76,366 | € 417,788 | € 27,150 | ▼ 94% |
| Cash | € 219,176 | € 8,164 | € 2,646,937 | € 136,662 | ▼ 95% |
| Retained profit | € 5,487,978 | € -2,387,194 | € -1,222,196 | € 725,136 | ▲ € 1.9 million |
| Balance sheet total | € 33,548,034 | € 25,689,172 | € 27,195,592 | € 28,752,286 | ▲ 6% |
Key figures of UCB Ventures Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to UCB Ventures Belgium?
What happened at UCB Ventures Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Alistair HENRY stepped down as director. NBB
- Jean-Christophe TELLIER stepped down as director. NBB
- Sandrine DUFOUR stepped down as director. NBB
- Denelle J. WAYNICK JOHNSON stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 1.9 million (▲ 67% vs 2024). Source: NBB ↗
- Alistair HENRY became a director. NBB
- Denelle J. WAYNICK JOHNSON became a director. NBB
- Jean-Christophe TELLIER became a director. NBB
In short
From € 1.5 million loss in 2022 to € 1.9 million profit in 2025.
Paid € 469,182 in corporate taxes since 2022.
Best year ever: 2025, with € 1.9 million profit.
A new publication or filing at UCB Ventures Belgium? We notify you, reason included.
Follow UCB Ventures BelgiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by UCB Ventures SA (100%) and UCB FIPAR SA (0%). It owns 11.5% of A. M. Pappas Life Science Ventures V, L, 8.6% of Qiming U.S. Healthcare Fund, L.P., 8.5% of Waterline Ventures III, LP., 5.3% of Sofinnova Digital Medicine I, 2.5% of Versant Venture Capital VI, L.P. and 1.4% of AMR Action Fund, L.P. itself.
Directors
According to the 2025 annual accounts
since 2022 · until 2028
since 2022 · until 2028
since 2024 · until 2030
since 2023 · until 2028
Shareholders
100%
0%
Participations
A. M. Pappas Life Science Ventures V, L
11.5%
Qiming U.S. Healthcare Fund, L.P.
8.6%
Waterline Ventures III, LP.
8.5%
Sofinnova Digital Medicine I
5.3%
Versant Venture Capital VI, L.P.
2.5%
AMR Action Fund, L.P.
1.4%
Establishments
Establishment units
Physical locations of this company
Researchdreef 60
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.
All companies at this address →UCB Belgium
U C B
UCB PHARMA same network
€ 4.6 billion revenue · 2025
UCB Fipar same network
Fondation Emmanuel Janssen
+5 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0668.388.891
- VAT number
- BE 0668.388.891
- Registered office
- Researchdreef 60, 1070 Anderlecht
- Names & denominations
- UCB Ventures Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 December 2016
- Peppol
- Not registered